Beam Therapeutics (BEAM) Non Operating Income (2020 - 2025)
Historic Non Operating Income for Beam Therapeutics (BEAM) over the last 6 years, with Q3 2025 value amounting to $14.1 million.
- Beam Therapeutics' Non Operating Income rose 4317.81% to $14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.6 million, marking a year-over-year increase of 2755.21%. This contributed to the annual value of $38.9 million for FY2024, which is 1425.07% down from last year.
- Per Beam Therapeutics' latest filing, its Non Operating Income stood at $14.1 million for Q3 2025, which was up 4317.81% from $17.9 million recorded in Q2 2025.
- In the past 5 years, Beam Therapeutics' Non Operating Income ranged from a high of $51.6 million in Q4 2022 and a low of -$17.3 million during Q2 2021
- In the last 5 years, Beam Therapeutics' Non Operating Income had a median value of $10.0 million in 2022 and averaged $11.9 million.
- As far as peak fluctuations go, Beam Therapeutics' Non Operating Income plummeted by 11781.17% in 2021, and later soared by 432207.69% in 2022.
- Beam Therapeutics' Non Operating Income (Quarter) stood at -$1.2 million in 2021, then soared by 4322.08% to $51.6 million in 2022, then tumbled by 78.11% to $11.3 million in 2023, then decreased by 14.35% to $9.7 million in 2024, then surged by 45.44% to $14.1 million in 2025.
- Its Non Operating Income stands at $14.1 million for Q3 2025, versus $17.9 million for Q2 2025 and $10.0 million for Q1 2025.